Regen Biopharma issues 21.4M shares in Jan 2026 for $69,550, massive dilution

Regen BioPharma Inc

On Jan 15, 2026, issued 5,000,000 shares to satisfy $11,449 principal + $8,101 interest on convertible debt.
On Jan 29, 2026, issued 5,302,732 shares to satisfy $12,000 principal + $1,000 interest.
On Jan 30, 2026, issued 11,111,111 shares for $50,000 cash via Reg A offering.
As of Feb 2, 2026, total shares outstanding: 129,468,577; implied average issuance price ~$0.003 per share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.